We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Evotec, Eternygen Partner to Develop Novel Metabolic Disease Therapy

Product News   Jan 10, 2017 | Original story from Evotec

 
Evotec, Eternygen Partner to Develop Novel Metabolic Disease Therapy
FURTHER INFORMATION
 
 
 

Related Product News

Developing Potent Affimer-drug Conjugates

Product News

Avacta and ADC Therapeutics are collaborating to produce Affimer-drug conjugates for patients suffering from hematological malignancies and solid tumors.

READ MORE

Incorporating AI Into Drug Discovery

Product News

Optibrium™ has announced the introduction of its Augmented Chemistry™ services, which provide collaborators with novel artificial intelligence technologies for drug discovery projects.

READ MORE

New Tablet Container: Modern, Child-resistant and Easy To Use

Product News

At CPhI Worldwide, Sanner GmbH will present its new child-resistant tablet container CR TabTec for the first time.

READ MORE

Like what you just read? You can find similar content on the communities below.

Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE